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Introduction
Faravelli et al. [1, 2] present findings on the lifetime,
point and 1-year prevalence of mental disorders from
their recent Sesto Fiorentino community survey in Italy.
The publication of these study findings occurs at a time
where some researchers and journal editors seem to have
come to the conclusion that there is currently no further
need for such cross-sectional studies on the prevalence of
mental disorders. In fact, there have been pleas for a
pause of such studies [3]. Highlighting several noteworthy
features and findings from the survey of Faravelli et al. [1,
2], this editorial will challenge this attitude. The status,
past and recent progress in the field of epidemiology of
mental disorders will be critically discussed, in an attempt
to underline the continued core role of descriptive epide-
miological studies for our field and to identify future
research needs.
What Is Epidemiology?
Epidemiology can be defined as the study of the distri-
bution and the determinants of disease frequency in
humans [4–6]. Key requirements of epidemiological stud-
ies are (a) the definition of the target population under
study, which can be either the total population of a region
or a country or representative fractions thereof (samples),
(b) explicit, reliable and valid criteria for disorders or
more generally what constitutes a ‘case’ (i.e. subjects with
key symptoms or syndromes, subjects with certain treat-
ment needs), (c) explicit, reliable and valid criteria for
variables and factors that might be associated with a dis-
ease (i.e. gender, social class, genetic factors, infectious
agents) to identify correlates, potential risk and protective
factors, and (d) use of epidemiological methods for mea-
suring outcome occurrence (incidence and prevalence
rates in specified time frames, such as lifetime, 30 days or
1 year) as well as the impact and consequences of mental
disorders, such as course of illness, associated impair-
ments and disabilities.
Epidemiology can further be divided into two interre-
lated orientations and methodologies, namely descriptive
epidemiology, aiming at measuring the size and scope of
mental disorders in the community or other populations
(prevalence and incidence) and analytic epidemiology,
which focuses on understanding the etiology of mental
disorders, for example by including psychosocial, labora-
tory or genetic markers and risk factors to test etiologic
hypotheses.
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Originally, in the scientific discipline of epidemiology,
epidemiological methods and research designs in particu-
lar were developed to study almost exclusively infectious
and a few chronic diseases. Only very slowly during the
past 40 years, methods were adapted for use in the field of
mental and behavioral disorders. This delay has been
mostly attributed to two factors: (a) the considerable com-
plexity of multifaceted vulnerability and risk constella-
tions typically seen for mental disorders and (b) the con-
troversial status of past diagnostic classification systems
for what has been called ‘psychiatric disorders’ in the past
[5, 6]. Still, the complex manifestations and courses of
mental disorders and their past low diagnostic reliability
were often difficult to capture in basic epidemiologic
designs, involving one or two assessment points in time.
In addition, risk factors for mental disorders remain to be
difficult to conceptualize and to assess as outcomes.
Despite these problems that have been partly over-
come in recent years, it is undisputed that epidemiology –
beyond the mere political implications of describing how
frequent mental disorders are in the community and how
frequently they are not treated – offers some unique and
most promising research strategies for describing and
clarifying the nature, the etiology, the course and outcome
of mental disorders. This is because patients in treatment
settings, on which most research and current knowledge is
based, usually represent only a small and highly selective
segment of the full spectrum of mental disorders and thus,
for example findings for risk factors, prognosis and etiolo-
gy might be biased by selection as well as severity of the
respective condition.
With the introduction of more reliable and valid classi-
fication systems for mental disorders, based on explicit
criteria and operationalized diagnoses in 1980 [7, 8] and
structured and standardized diagnostic assessment instru-
ments [9] tailored accordingly, the last two decades have
witnessed an unprecedented progress for epidemiological
research in mental disorders in terms of number of stud-
ies, their scope, degree of methodological sophistication
and their linkages to allied disciplines such as psychology,
psychotherapy, neurobiology, and sociology [9]. What
started in the 1950s as a scientifically problematic and
quite restricted area of research in ‘psychiatric epidemiol-
ogy’, plagued by basic conceptual problems of case defini-
tion, the establishment of stable prevalence estimates, and
the preoccupation with studying social class issues and
psychosocial correlates of a few disorders [10–12], has
now reached firmer grounds. Within a comprehensive
and broader perspective of ‘epidemiology of mental disor-
ders’, important interdisciplinary contributions for a wid-
er range of mental disorders emerged that are relevant not
only for psychiatry, but also for the fields of neurobiology,
genetics, clinical psychology, psychotherapy and psycho-
somatics, and public health.
Progress in Descriptive Epidemiology
The Size of the Problem: Prevalence, Age of Onset,
Undertreatment
Increasingly sophisticated, large-scale studies in the
general population (descriptive epidemiology) have made
evident to researchers, clinicians, as well as the public
that mental disorders are very frequent disorders of the
brain, affecting almost every other person over his/her
life course. Whereas in the 1970s and early 1980s we were
concerned with unreliability of findings, manifested by
tremendously large 2- to 3-fold prevalence variations for
even a few broad diagnostic categories like the ‘neuroses’,
more recent findings have provided us with fairly consis-
tent prevalence estimates for a wide range of specific
mental disorders across countries. These studies have fur-
ther highlighted with increasing precision the variability
in the manifestations of disorders of emotion, cognition
and behavior, demonstrating that mental disorders are
not as uniform as previously believed in terms of their
risk factors, courses, outcomes, associated disabilities and
impairments. The demonstration of disorder-specific
characteristics of mental disorders has important clinical
implications and matches for example evidence from
clinical research in psychotherapy and neuropharmacolo-
gy that, despite some common factors, successful man-
agement of patients requires disorder-specific interven-
tions.
As an example, the International Consortium in Psy-
chiatric Epidemiology [13] estimated on the basis of a
joint reanalysis of several countries the lifetime risk for
the three most common disorders (mood, anxiety and
substance disorders) to range between 36.3 and 48.6%
and the point (30-day) prevalence to range between 10
and 17%, in spite of design and cultural differences [14–
17]. Similar relative stable estimates were found even for
specific disorders, such as panic disorder (lifetime esti-
mates of 3–4% and point prevalence estimates of 1–2%)
as well as psychotic disorders (1–3%). Similar convergent
evidence has also become available from these studies
with regard to sociodemographic correlates, the temporal
patterns in terms of onset and persistence, impairments
[18] of mental disorders, the high degree of cross-sectional
[19] and sequential comorbidity among various forms of
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mental disorders [20], and the fairly low service utiliza-
tion rates for most mental disorders, which range between
7 and 13.4% in industrial countries.
Progress in this domain is not of mere academic inter-
est, but has also important implications for practitioners,
the public, the patients and their families. Descriptive
epidemiological data of this sort have helped significantly
to ‘demystify’ mental disorders. For example, politicians,
increasingly aware of the fact that almost 50% of the pop-
ulation suffers at least at one point in time of at least one
mental disorder, have started to put mental health care
and the implementation of appropriate treatment struc-
tures higher on the agenda and primary care physicians
get increasingly aware of the size and scope of mental dis-
orders in their patients, referring them more frequently to
specialist treatments (psychotherapists, psychiatrists).
Those suffering from mental disorders increasingly know
that they are not single and rare cases suffering from
untreatable ‘craziness’, but have specified disorders, for
which various effective psychological and pharmacologi-
cal treatments exist.
The Impact of Mental Disorders in Terms of Disability
Findings also make clear that mental disorders, includ-
ing substance use disorders, are quite disabling condi-
tions. Supported by a few epidemiological data, available
at the time of this exercise, the Global Burden of Disease
study [21] estimated, using expert ratings, that the burden
associated with mental disorders has been heavily under-
estimated. Of the 10 leading causes of disability world-
wide in 1990, measured in years lived with a disability, 5
were psychiatric conditions: unipolar depression, alcohol
use, bipolar affective disorders, schizophrenia and obses-
sive-compulsive disorder. At the same time, it is notewor-
thy that the Global Burden of Disease study clearly stated
that these estimates rely predominantly on fairly crude
expert estimations, without sufficient support by actual
data. In response to this deficit, increased national and
international collaboration and the use of more stringent
methodologies and designs have resulted in intensified
attempts to collect more comprehensive data, allowing for
coordinated cross-national reanalysis such as the ongoing
World Mental Health 2000 [22]. The significance of such
studies beyond the mere demonstration of the size of the
problem of mental disorders has been highlighted by the
Cross-National Group, which demonstrated increasing
rates of depressive disorder in each successively younger
birth cohort as well as declining age of first onset of
depressive disorders in almost all countries examined
[23]. This has prompted several studies to explore the rea-
sons for this continuing increase in depression rates and
further led to a reconsideration of projections with regard
to the burden of depressive disorders in the future.
The Relevance of Epidemiological Studies for
Improved Classification and Instruments
Population studies and method-related epidemiologi-
cal work have also been instrumental in the improvement
of diagnostic classification systems for mental disorders.
Reliable symptom and diagnostic assessment instruments
of mental disorders have been created for use in epidemi-
ology and clinical research, such as the Composite Inter-
national Diagnostic Instrument (CIDI) [24] with its varia-
tions, gradual incorporation of findings by survey metho-
dologists and cognitive psychologists [25, 26]. This work
has not only significantly influenced the content and
structure of clinical instruments such as the Structured
Clinical Interview for DSM-IV [27, 28] and the Schedules
for Clinical Assessment in Neuropsychiatry [29, 30], but
also played an important role in the revision processes of
diagnostic classification systems (DSM-IV, ICD-10 and
DSM-V), resulting in further refinement of explicit diag-
nostic criteria and algorithms with improved reliability
and a more detailed exploration of empirically based
thresholds.
A Broader Understanding of the Nature of Mental
Disorders – Comorbidity
Epidemiological studies have also been instrumental in
highlighting the important role of comorbidity. Careful
cross-sectional studies in the community have demon-
strated that comorbidity is not merely an artifact or a
result of help seeking, but a core characteristic of almost
all mental disorders, which seems to have important noso-
logical and clinical implications [31, 32], such as in the
case of early-onset primary anxiety disorders and second-
ary major depression. Since the nature and the meaning of
this comorbidity is yet poorly understood and conceptual-
ized, such evidence has stimulated an increasingly com-
plex set of studies, with the attempt to identify the impli-
cations of comorbidity for defining more appropriate
thresholds and more convincing nosological models.
Unresolved Issues in Descriptive Epidemiology
Given the quite impressive list of progress, it is note-
worthy though that there remains a considerable list of
unresolved issues, which clearly call for continued strong
efforts to conduct cross-sectional epidemiological studies
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in the community. Although some reviewers [3, 33] in the
field have criticized the ‘what has been labelled past
preoccupation with large-scale general population stud-
ies’, it seems important to emphasize that there is poor
support for the assumption that the core critical issues are
resolved. In the following part, I will address some of
these deficits, highlighting at the same time the degree to
which Faravelli et al. [1, 2] help us to fill these gaps in
knowledge.
The Need for Country-Specific Prevalence Data
To start with a more general political perspective, it is
first noteworthy that politicians and health care planners
will have lasting interests in continuous monitoring of the
mental health state of the respective population they are
responsible for. In this respect, it should be noted that
actually only very few countries ever conducted and pub-
lished nationwide surveys on this topic; among the few are
the USA, Canada, Germany, the UK, the Netherlands,
and Korea. Somehow more studies are available from cir-
cumscribed smaller areas [34–36]. Yet, one should also
note that some of these studies were conducted many
years ago; thus, they might neither reflect the current situ-
ation nor current provider and treatment standards; fur-
ther, older data might not be up to date anymore in meth-
odological terms (diagnostic criteria, sampling).
This concern is particularly relevant in times of chang-
ing diagnostic criteria (DSM-III to DSM-IV), changing
provider models (increasing role of nondrug interventions
and ambulatory treatment), changing evidence for ‘first-
line treatments’ (type of medication, type of psycho-
therapy) and with regard to time trends, for example with
regard to drug abuse (cannabis, stimulants), where rapid
changes might occur even in time intervals of a few
years.
In this respect, Faravelli et al. [1, 2] present for Italy the
most recent prevalence and treatment data. After their
landmark ‘Florence’ study in the 1980s, their novel con-
tribution is the fourth prevalence examination for Italy. A
fifth one – as part of the European ESEMED/MHEDEA
trial – might become available in about a year. The partic-
ular strength of their study is that their methodology
allows comparisons with previous surveys, for example to
estimate stability and change of prevalence rates over
time. Further, their study is among the few also informing
about the treated prevalence, hospitalization rates, and
therapeutic interventions. These data highlight that still
after many years of attempts to increase recognition,
treatment rates, and rates for appropriate treatment, rates
for roughly adequate treatment remain quite low. As in
some other epidemiological studies [37, 38], the predomi-
nant provider for mental health treatment remain prima-
ry care doctors in 87% of all treated persons affected by
mental disorders. This might also explain, why benzodi-
azepines are still the most frequent treatment applied,
inspite of the fact, that this treatment is not regarded as a
first-line treatment anymore for almost all diagnoses cov-
ered in this survey.
Incomplete Coverage of Disorders
A second critical deficit is that past epidemiological
studies actually assessed only very few of the existing dis-
orders codified in our classification manuals for mental
disorders. Undoubtedly, there is now an impressive body
of evidence on the prevalence of many threshold disor-
ders, particularly psychotic disorders, substance use, anxi-
ety, and affective (mood) disorders. Yet, these disorders
are far from covering the full range of clinical significant
psychopathological conditions.
Noteworthy deficits exist, however, for example with
regard to the prevalence of threshold conditions of soma-
toform disorders, sleep disorders, eating disorders, sub-
stance-related disorders beyond abuse and dependence,
personality disorders, and some forms of childhood disor-
ders. Given that many of these neglected conditions are
believed to be very prevalent and play a particularly
important role in psychotherapy and psychosomatics and
primary care, each of these conditions merits consider-
able epidemiological attention from a public health per-
spective alone. Since these disorders also have different
onset and course characteristics and are frequently associ-
ated with the development of secondary comorbidities
(i.e. major depression and substance dependence), they
might also be promising targets for a better understanding
of pathogenetic pathways involved.
Nevertheless, for example somatoform disorders (i.e.
pain disorders, hypochondriasis, somatization), believed
to be highly prevalent conditions, starting early in life and
constituting a major burden on the health care system
[39], have rarely been studied in past surveys. Similarly,
sleep disorders, highly ranked as a reason for primary care
consultations [40], have not been systematically studied
up to now in community surveys. One might speculate
that the yet unclear nosological status in classical psy-
chiatric terms have put these two conditions low on the
priority scale for large-scale population studies.
The obstacles to epidemiological research on personal-
ity disorders have been attributed to methodological rea-
sons, namely the lack that up to now there have not been
any sufficiently reliable and time-efficient assessment
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tools suitable for comprehensive, epidemiological assess-
ments.
For childhood conditions, the challenges lie in the lack
of consensus and in the appropriate choice of age-/de-
velopmental-stage-specific diagnostic assessments. Re-
searchers must also concur on the degree to which multi-
ple sources of information (i.e., parents and teachers ) can
be combined into one coherent strategy that mirrors the
continuity to adolescent and adult mental disorders. In-
deed, despite growing collaboration, there is still a re-
markable division between epidemiological designs and
methods used in childhood, adolescent and adult mental
disorder research. Inherent in this division is the issue of
the developmental continuity of psychopathological fea-
tures, which partly also touches on the ongoing controver-
sy of dimensional versus categorical measures in epidemi-
ological studies of mental disorders. Intensified research
in this area is needed especially because of evidence that
most of the adult mental disorders begin in adolescence.
The contribution of Faravelli et al. [1, 2] is noteworthy
from this perspective because their study has made a seri-
ous attempt to at least fill some of these gaps. Unlike most
previous surveys, their study’s assessment tool allowed
estimates for rates of primary sleep disorders, childhood
conditions, eating disorders, somatoform and impulse-
control disorders. Despite the fact that a certain note of
caution is necessary with regard to the formal integrity of
these diagnoses in terms of reliability and validity, these
data provide a unique opportunity to describe the mental
health state in the community more comprehensively
than most other studies in the past. Further, these diag-
nostic additions open up the unique possibility to exam-
ine patterns of comorbidity more adequately.
Threshold Explorations and Subthreshold Disorders
With few, but noteworthy exceptions [41, 42], avail-
able descriptive epidemiological survey data refer to a
quite restricted range of threshold DSM diagnoses, usual-
ly derived from the CIDI or similar instruments without
consideration of available duration, persistence and se-
verity information. The exclusive reliance on categorical
threshold diagnoses carries substantial risks of artifactual
explanations (such as in comorbidity analyses) and fails to
acknowledge the possibility of a dimensional nature of
most expressions of psychopathology. The DSM-IV, as
the most frequently used classification system for mental
disorders in research, actually makes only a few explicit
attempts to derive discrete categories that are mutually
exclusive and lead to a single classification of an individu-
al. In fact, the system was intended to stimulate further
development of research on the thresholds for and bound-
aries between disorders [8]. However, regrettably few
researchers have taken this as a starting point for detailed
and systematic threshold explorations to provide such
urgently needed data that would ultimately help to derive
more adequate diagnostic classes and classification sys-
tems. Available data with their primary reliance on cate-
gorical diagnostic decisions are not an optimal source for
modifying diagnostic systems [43].
The work by Faravelli et al. [1, 2] might ultimately be
able to contribute quite valuable data to these critical
issues as well. Based on a 2- or rather 3-stage epidemiolog-
ical strategy, cases in their study were first evaluated with
a screening tool, the Mini-International Neuropsychiatric
Interview [44], and subsequently in stage 2 by the Flor-
ence Psychiatric Interview, followed by a reappraisal in
selected clinical cases. The fact that this assessment strate-
gy was applied by clinical interviewers using structured
clinical interview tools allows the authors to employ a
quite detailed severity model with regard to both, symp-
toms as well as syndromes. This quite innovative and
novel complex assessment procedure will ultimately allow
a series of threshold modulations. Yet, it should be noted
that the two papers in this volume do not yet report any
detailed data about the outcome of this interesting op-
tion.
Assessment of Disability and Need for Treatment
Over the past years, increasing recognition emerges
that most diagnoses of mental disorders in themselves
cannot appropriately answer questions about the need for
care, service utilization, and treatment match. Such do-
mains are thought to be largely determined by the func-
tioning status and disability as well. Epidemiological stud-
ies from the past two decades have not provided coherent
and comprehensive information about these important
issues, beyond a few limited general indicators of interfer-
ence (questions such as ‘did this interfere with your life
and activities a lot..?’). Thus, epidemiological studies at
this point do not allow reliable characterizations of diag-
nosis-specific degrees of disability nor the associated ser-
vice needs [45] that might be strongly linked to disability.
It is only very recently that systematic conceptual and
psychometric developmental work has been started by the
WHO to design generic and diagnosis-specific assessment
instrument modules to assess disability [46], and these
measures might also provide a better basis for need assess-
ment.
Although several authors [45, 46] have suggested direct
links of improved disability and need measures, they have
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failed to acknowledge that our current database is also
largely deficient concerning matters of help seeking, pat-
terns of service utilization, and intervention received.
Questions like ‘have you talked with a doctor about a syn-
drome?’ fail to acknowledge the wide range of services
(psychiatric, psychostherapeutic, psychosocial) and effec-
tive treatment and provision modalities available in most
developed health care systems. Thus, the currently avail-
able epidemiological data are unlikely to give reliable –
and, more importantly, sufficiently detailed – informa-
tion about the degree of nonrecognition, treatment rates
and help-seeking patterns of disorders. As a result, they
are not helpful and informative enough to guide us in
making improvements.
The work of Faravelli et al. [1, 2] can be expected to
also make some important contributions to this impor-
tant domain. Because of their use of clinical interviewers
and the level of detail with regard to impairments, longi-
tudinal course, and threshold considerations, this study
can also be expected to provide improved information
about the relationship of symptom and syndrome constel-
lations with impairment and help-seeking behavior on the
one hand, and the probability of receiving treatment on
the other hand. Yet, it should also be recognized that
threshold exploration in cross-sectional studies have seri-
ous limitations, which might only be sufficiently over-
come by longitudinal designs (see below).
Unresolved Research Issues
The Need of Further Cross-Sectional Studies
The past emphasis on large-scale general population
surveys seems to have led to the partly unfortunate public
perception that the sole goal and past decade’s achieve-
ments of epidemiology in mental disorders is simply the
derivation of population-based rates and the identifica-
tion of a few sociodemographic correlates. This miscon-
ception has overlooked the numerous and considerable
deficits discussed above on the one hand and the contin-
ued need and value of improved cross-sectional preva-
lence studies in the community on the other hand. It is
certainly true, that cross-sectional studies have their limi-
tations, and it is also evident that there is a pressing need
for longitudinal studies. Yet, one should not give up one
goal at the expense of the other.
Further, the exclusive reliance on longitudinal studies
overlooks that each longitudinal study starts with a cross-
sectional baseline survey; the better the methodology of
this baseline survey is, the more likely it is that an ulti-
mate follow-up will resolve effectively the open research
questions. Clearly more studies of the type of Faravelli et
al. [1, 2] have completed are needed for many countries in
Europe and worldwide, even more so, if they address
more comprehensively than studies in the past broader
clinical and public health issues along with a higher degree
of psychopathological sophistication.
... and Beyond: Natural Course, Developmental
Pathways, Core Psychopathological Processes
The value of such cross-sectioal community studies,
however, could be tremendously enhanced, if such studies
continue with prospective longitudinal cohorts. Evident-
ly, despite a slowly growing number of costly large-scale
prospective-longitudinal studies [41, 47–49], our knowl-
edge about natural course, longitudinal stability of symp-
toms and comorbid associations, as well as vulnerability
and risk factors for the onset and persistence of mental
disorders is still quite meager. For example, the ‘causal
risk factor’ status [50] has not yet been established for
most putative risk factors of mental disorders, and at this
point it remains unclear what might be cause, conse-
quence, or a mere correlate. Nevertheless, an increasing
number of prospective-longitudinal epidemiological stud-
ies have been launched and have already or are expected
to make significant contributions to nosology, by provid-
ing an increasingly sharper picture of natural course, early
signs and risk factors, especially in children, adolescents,
and young adults [41, 47, 48, 51, 52]. Optimally such
studies should allow to link epidemiological psychopatho-
logical data directly with basic and clinical psychological
and neurobiological research.
The limitations of patient and convenience samples for
etiological and pathogenic research are becoming increas-
ingly recognized. These include the risks of artifactual
findings, the over- and underestimation of effects, confu-
sion by comorbidity, and the impossibility of establishing
causal risk factors for the first onset of a disorder. Pro-
spective-longitudinal studies in representative population
samples and causal-analytic designs will thus be of central
importance.
Beyond etiopathogenesis, such studies are also of core
importance for the identification of what we ultimately
are all looking for: core psychopathological processes that
might form a firmer basis for better diagnostic classifica-
tions. In this respect, Krüger’s [32] recent thought-pro-
voking extension of an interesting data analytic approach
to studying comorbidity needs mentioning. Elaborated
initially with longitudinal data from the Dunedin birth
cohort with 18- to 21-year-olds, he investigated the factor
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structure underlying some common DSM-III-R mental
disorders in the National Comorbidity Survey cross-sec-
tional sample of 15- to 65-year-olds [18] in an effort to
elucidate the broad higher-order structure of phenotypic
psychopathology or ‘core psychopathological processes’,
which themselves might be foci for research on treatment,
prevention and etiology. The demonstration of the rela-
tive continuity of findings in both the Dunedin and
National Comorbidity Survey samples is noteworthy and
adds to the credibility and implications of his findings.
His findings seem to match similar evidence from child
psychiatry, psychiatric genetic and psychopharmacologi-
cal research, suggesting that his model might not be phe-
notypic but may actually organize common psychopatho-
logical variance in terms of shared genetic epidemiology.
However, given several significant limitations of this
study, it is unwise and premature to draw strong and dog-
matic conclusions on the basis of the current analyses
[33]. But it certainly provides a stimulating example of
how even reanalyses of existing data sets may contribute
to our advancement of knowledge.
The Continued Search for Improved Conceptual
Models of Mental Disorders 
Conceptual models of mental disorders are not and
have never been a paragon of elegance, nor have they
resulted in sufficiently neat and crisp classification sys-
tems that match basic research findings and clinical man-
agement decision making. This certainly also applies to
today’s comprehensive modern classification systems,
ICD-10 and DSM-IV, which use a more ‘descriptive
approach’ with explicit criteria and specified diagnostic
algorithms. The introduction of these manuals has re-
sulted in greater diagnostic reliability and consistency in
the use of diagnostic terms around the world, and has also
been a key prerequisite for epidemiological progress in
particular. However, there are still significant problems
that are a source of significant dissatisfaction and contro-
versy and require extensive future work, as evidenced by
the core questions currently being explored in the revision
processes of future ICD and DSM classifications. In the
center of this agenda is the need for convincing clinical
and nosological validation in terms of prognostic value
and stability, family and genetic findings, and laboratory
findings for almost all mental disorders [53], ultimately
allowing a sharper genotypical and phenotypical classifi-
cation. The ICD-10 and DSM-IV systems deliberately do
not contain many mutually exclusive diagnostic catego-
ries, and they were intended to simulate inquiries into
diagnostic boundaries and thresholds. These areas are
optimal targets for epidemiological research, yet few have
done this systematically.
One likely reason for this deficit is the remaining lack
of consensus on how to tailor appropriate psychopatho-
logical assessment instruments. Despite the substantial
scientific exploration and examination that went into
existing instruments like the CIDI, Structured Clinical
Interview for DSM-IV and Schedules for Clinical Assess-
ment in Neuropsychiatry, basic problems of reliability
and validity inherent in mental disorder assessment re-
main unresolved. Unlike in the past, however, these criti-
cal issues are now themselves serious subjects of scientific
research that encourage close collaborations between the
designers of diagnostic manuals, clinical researchers and
epidemiologists. Researchers are utilizing the tremen-
dously rich database of psychometric evaluations that
have resulted from diagnostic interview research, cogni-
tive psychology, and survey methodologists [54]. In the
center of discussion is no longer the old question of wheth-
er to use a categorical or a dimensional approach (there
seems to be agreement that diagnostic interviews should
offer both), but rather to what degree and for which psy-
chological conditions ‘clinical judgement and probing’
should be regarded as a mandatory core element. Future
methodological studies will hopefully resolve this ques-
tion. Empirical evidence must also be gathered to deter-
mine in which diagnostic domains semi-structured clini-
cal instruments are really superior to fully standardized
instruments like the CIDI, which try to explicitly identify
the latent variables behind the vagueness of clinical judge-
ment. Progress in the resolution of this issue will ultimate-
ly also offer us more appropriate approaches to resolve the
‘gold standard’ question of the optimal strategy to vali-
date epidemiological instruments [55, 56]. In this respect,
Faravelli et al. [1, 2] have presented a stimulating exam-
ple of the variability of possible approaches integrated
into one, admittedly quite complex, approach.
Need Evaluation and Its Implications on Interventions
in the General Population 
Epidemiology has to offer unique methodologies to the
complex process of need assessment and related evalua-
tive activities [5, 6], and epidemiological data are a key
prerequisite for identifying deficits and problems in
health care systems, and offering guidance in service plan-
ning and resource allocation. In times of an increasing
number of effective pharmacological and psychological
treatments, competing provider models for mental disor-
ders, and tighter health care budgets, epidemiology can be
expected to gain further importance. But certainly the
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available studies and data do not yet provide us with an
appropriate level of detail for this important task [45, 57].
One noteworthy exception may be the considerable body
of research in schizophrenia and the psychotic disorders
[58], which are particularly disabling and chronic, but
quite low in prevalence. The basic prerequisites of such
more comprehensive studies seem to be in place: clearly
specified disorder and/or related disability for which an
effective and acceptable treatment is available or can be
provided.
Nevertheless, despite the existence of many effective
psychological and drug treatments shown to prevent dis-
ability, relapse, chronicity and suffering, we identified
only one epidemiological study that assessed recognition
and utilization issues in detail by type of diagnosis and
severity [18]. In all other studies, nothing more was asked
beyond whether the patient had contacted a medical doc-
tor (or other mental health specialists). In this respect, the
fairly continuous ignorance of taking into account the full
range of mental health providers and in particular psycho-
therapeutic approaches has been particular noteworthy
[57].
During the past two decades, quite comprehensive,
interdisciplinary, mental health systems of providers have
emerged in most industrialized countries. But up to now,
no epidemiological survey has been able even to answer
simple questions like: how many anxiety or depressive
disorders were treated by psychiatrists, psychotherapists
or other types of providers; how many were treated by
medication or some form of psychological treatment, or
how many were treated at in- or outpatient institutions.
Further, although the traditionally broad clinical concept
of ‘neurosis’ as well as oversimplified dichotomies of so-
called ‘minor’ and ‘major’ mental disorders have clearly
outlived its usefulness and scientific justification, some
health utilization and needs surveys still rely on such diag-
nostic concepts. Even though the so-called ‘minor’ mor-
bidities (such as somatoform and anxiety disorders) are
treatable, rank among the most prevalent and persisting
conditions, and cause by far the greatest financial burden
of all disorders [59], many studies estimating needs for
treatment and services still overemphasize the assumed
‘more severe major’ disorders that are of considerably
lower prevalence.
Strongly related with this traditional distinction, such
traditional studies also seem to favor the position that
minor morbidities are perfect targets for primary care
physicians, whereas only ‘major mental disorders’ require
mental health specialist intervention. Even though the
quite limited abilities of primary care physicians to recog-
nize, diagnose and treat most of the mental disorders has
repeatedly been highlighted throughout the world [46], it
seems that traditional psychiatric epidemiology still
seems to strongly favor this model. In contrast, more com-
prehensive service utilization and need assessment strate-
gies for mental health specialists regarding anxiety, soma-
toform and other ‘minor’ morbidities are evidently low on
the priority list of most community surveys. It is impor-
tant here to emphasize that the current attempts to link
such simplified models to measures of disability, in order
to improve need assessment (see above) might not solve
this critical problem. Rather, I assume, it might result
again in an inappropriate strong emphasis on the most
severely ill, neglecting those in earlier stages of their ill-
ness process who might profit most of our modern treat-
ment methods.
Certainly it is neither adequate nor financially feasible
to equate diagnostic status directly to treatment needs,
given the high prevalence of mental disorders and the
considerable degree of comorbidity present among those
with a particular diagnosis. Rather we should make trans-
parent that this is rather a question of health care policy
than a question of science. Further, it seems promising to
start systematic testing of various competing models that
already exist around the world. For example, health care
systems that are neither able nor willing to offer compre-
hensive and highly specialized mental health care inter-
ventions for their population will probably have different
priorities (i.e., ‘care only for the most severe!’) than com-
prehensive systems that might feel able to offer fairly
unrestricted access to drug and psychotherapeutic treat-
ments, even free of charge, with the ultimate hope to
reduce the proportion of patients with severe complica-
tions on the long run. Similar to somatic medicine, and
particular highly prevalent conditions such as hyperten-
sion, where it took many years to recognize its malignant
effects on long-term course and outcome and on the
pathogenesis of associated conditions like diabetes, ne-
phropathy and cardiovascular disease, time seems to have
come to test, whether early and intensive treatment of
highly prevalent early-onset anxiety and somatoform
might not result in a lower incidence of negative health
outcomes and secondary complications, such as lower risk
of major depression, suicide, chronicity and disability.
Priorities regarding assessment tools and evaluative
activities will necessarily vary widely by region and sys-
tems. Some systems will primarily aim at the identifica-
tion of the ‘severely ill’ to ensure basic care for those most
disturbed and disabled, others will aim to optimize re-
sources beyond the very ill, including prevention, early
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treatment, and a much wider range of drug and behavior-
al treatments with established effectiveness. Some might
even aim at universal primary prevention of mental disor-
ders (i.e., reducing illness incidence), despite increasingly
discouraging results of such universal prevention trials.
Others will shift efforts to secondary prevention to reduce
risk among those susceptible.
The challenge for epidemiology on a cross-national and
international basis lies in a systematic comparison of such
competing models [60]. Developing appropriate assess-
ment instruments for use in epidemiological studies to
identify advantages and disadvantages of each of these
perspectives, in terms of legal, cost, comprehensiveness
and effectiveness issues is a stimulating and necessary
first step. Current perspectives on this issue seem to over-
emphasize two search strategies: the development of reli-
able and valid measures of disability [45, 46], and the
search for other ‘marker’ variables of those in greatest
need or the ‘most severe’. In light of the above concerns,
this perspective seems to fall too short. In search of
improved approaches for comprehensive need assess-
ment and evaluation, future epidemiological research
should additionally emphasize: (a) a more comprehensive
assessment of help-seeking behaviors that covers the full
spectrum of professional providers in the respective coun-
try or region, (b) a wider coverage of types of interven-
tions received, contingent on the availability of treat-
ments in that country for that diagnosis, and (c) a detailed
inquiry of perceived barriers to recognition and treat-
ments.
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